A. Busemann
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
-
- Drug Transport and Resistance Mechanisms
Papers in
- Co-authors
- Claus-Dieter Heidecke (17 shared papers)Werner Siegmund (2 shared papers)Stefan Oswald (2 shared papers)Tobias Traeger (9 shared papers)Stephan Diedrich (7 shared papers)Katharina Cziupka (8 shared papers)Yurong Lai (1 shared paper)C.-D. Heidecke (4 shared papers)
- Journals
- Journal of Pharmaceutical and Biomedical Analysis (2 papers)Journal of Visualized Experiments (2 papers)Pharmaceutics (1 paper)Inflammation Research (1 paper)Journal of Clinical Nursing (1 paper)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
A. Busemann
31 papers receiving 507 citations
Peers
Comparison fields: 5 of 89
- Pharmacology 93
- Oncology 172
- Critical Care and Intensive Care Medicine 16
- Pediatrics, Perinatology and Child Health 59
- Biochemistry 23
Countries citing papers authored by A. Busemann
This map shows the geographic impact of A. Busemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Busemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Busemann more than expected).
Fields of papers citing papers by A. Busemann
This network shows the impact of papers produced by A. Busemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Busemann. The network helps show where A. Busemann may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Busemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 118 | |
| 2 | 2014 | 82 | |
| 3 | 2010 | 77 | |
| 4 | 2012 | 44 | |
| 5 | 2010 | 39 | |
| 6 | 2012 | 29 | |
| 7 | 2010 | 26 | |
| 8 | 2010 | 14 | |
| 9 | 2010 | 12 | |
| 10 | 2020 | 10 | |
| 11 | 2011 | 9 | |
| 12 | 2012 | 7 | |
| 13 | 2020 | 6 | |
| 14 | 2023 | 6 | |
| 15 | 2011 | 4 | |
| 16 | 2013 | 4 | |
| 17 | 2012 | 3 | |
| 18 | 2013 | 3 | |
| 19 | 2010 | 3 | |
| 20 | 2013 | 3 |
About A. Busemann
A. Busemann is a scholar working on Surgery, Oncology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Emergency Medical Services, having authored 34 papers that have together received 514 indexed citations. Recurring topics across this work include Patient Safety and Medication Errors (4 papers), Cardiac, Anesthesia and Surgical Outcomes (3 papers), Musculoskeletal Disorders and Rehabilitation (3 papers), Pancreatitis Pathology and Treatment (3 papers), Sepsis Diagnosis and Treatment (2 papers), COVID-19 and healthcare impacts (2 papers), Vascular Tumors and Angiosarcomas (2 papers) and Medical Malpractice and Liability Issues (2 papers). The work is most often cited by research in Pharmacology (93 citations), Oncology (172 citations), Critical Care and Intensive Care Medicine (16 citations), Pediatrics, Perinatology and Child Health (59 citations) and Biochemistry (23 citations). A. Busemann has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Claus-Dieter Heidecke, Werner Siegmund, Stefan Oswald, Tobias Traeger, Stephan Diedrich, Katharina Cziupka, Yurong Lai, C.-D. Heidecke, Wolfram Keßler and Markus M. Lerch. Their work appears in journals such as Journal of Pharmaceutical and Biomedical Analysis, Journal of Visualized Experiments, Pharmaceutics, Inflammation Research and Journal of Clinical Nursing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.